Shanghai Aladdin Biochemical Technology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005XD0
CNY
22.85
0.65 (2.93%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Negative results in Sep 25

  • INTEREST(HY) At CNY 16.36 MM has Grown at 901.87%
  • NET PROFIT(HY) At CNY 33.51 MM has Grown at -39.53%
  • ROCE(HY) Lowest at 7.97%
2

With ROE of 9.77%, it has a expensive valuation with a 4.12 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 4,399 Million (Mid Cap)

stock-summary
P/E

42.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.69%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

10.17%

stock-summary
Price to Book

4.13

Revenue and Profits:
Net Sales:
171 Million
(Quarterly Results - Mar 2026)
Net Profit:
37 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
41.14%
0%
41.14%
6 Months
75.23%
0%
75.23%
1 Year
35.37%
0%
35.37%
2 Years
34.33%
0%
34.33%
3 Years
-29.43%
0%
-29.43%
4 Years
-63.82%
0%
-63.82%
5 Years
-74.79%
0%
-74.79%

Shanghai Aladdin Biochemical Technology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
21.86%
EBIT Growth (5y)
11.73%
EBIT to Interest (avg)
81.15
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.33
Tax Ratio
9.80%
Dividend Payout Ratio
55.91%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.10%
ROE (avg)
9.56%

Valuation key factors

Factor
Value
P/E Ratio
42
Industry P/E
Price to Book Value
4.12
EV to EBIT
34.19
EV to EBITDA
26.60
EV to Capital Employed
3.92
EV to Sales
7.70
PEG Ratio
NA
Dividend Yield
1.19%
ROCE (Latest)
11.47%
ROE (Latest)
9.77%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 31.11% vs 32.18% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 26.01% vs 73.10% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "170.70",
          "val2": "130.20",
          "chgp": "31.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "45.40",
          "val2": "43.70",
          "chgp": "3.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "1.30",
          "chgp": "307.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.30",
          "val2": "29.60",
          "chgp": "26.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "265.70%",
          "val2": "263.20%",
          "chgp": "0.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 30.34% vs 31.67% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 16.77% vs 34.85% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "690.40",
          "val2": "529.70",
          "chgp": "30.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "214.80",
          "val2": "170.30",
          "chgp": "26.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "28.20",
          "val2": "8.40",
          "chgp": "235.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.90",
          "val2": "0.40",
          "chgp": "-825.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "135.10",
          "val2": "115.70",
          "chgp": "16.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "250.00%",
          "val2": "242.20%",
          "chgp": "0.78%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
170.70
130.20
31.11%
Operating Profit (PBDIT) excl Other Income
45.40
43.70
3.89%
Interest
5.30
1.30
307.69%
Exceptional Items
-0.00
-0.20
100.00%
Consolidate Net Profit
37.30
29.60
26.01%
Operating Profit Margin (Excl OI)
265.70%
263.20%
0.25%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 31.11% vs 32.18% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 26.01% vs 73.10% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
690.40
529.70
30.34%
Operating Profit (PBDIT) excl Other Income
214.80
170.30
26.13%
Interest
28.20
8.40
235.71%
Exceptional Items
-2.90
0.40
-825.00%
Consolidate Net Profit
135.10
115.70
16.77%
Operating Profit Margin (Excl OI)
250.00%
242.20%
0.78%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 30.34% vs 31.67% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 16.77% vs 34.85% in Dec 2024

stock-summaryCompany CV
About Shanghai Aladdin Biochemical Technology Co., Ltd. stock-summary
stock-summary
Shanghai Aladdin Biochemical Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available